Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Xiaobai Li
Based on 4 articles published since 2008
||||
Expertise Level

  What is this?

Expertscape's algorithms degrade at low publication numbers. Thus, with only 4 published articles on Pancreatic Neoplasms from 2008 through 2019, it is not possible for Expertscape to reliably rate Xiaobai Li's expertise on this topic.

Uncounted papers?
Work Locations
Details
Most likely:    Ohio State University   Contact    
2014
  • Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH. · Department of Internal Medicine, The Ohio State University, Columbus, OH. · Center for Biostatistics, The Ohio State University, Columbus, OH. · Department of Surgery, The Ohio State University, Columbus, OH. · Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH. · Pubmed 24046122
2013
  • Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA. · Pubmed 22786786
2011
  • Ohio State University Comprehensive Cancer Center, Arthur James Cancer Hospital, Columbus, OH, 43210, USA. · Pubmed 20461379
2009
  • Department of Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA. · Pubmed 19307739
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Xiaobai Li in 2008-2019 about Pancreatic Neoplasms:

  • The addition of radiation to chemotherapy does not improve outcome when compared to chemotherapy in the treatment of resected pancreas cancer: the results of a single-institution experience. 2014
  • Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials. 2013
  • A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas. 2011
  • Fixed-dose-rate gemcitabine in combination with oxaliplatin in patients with metastatic pancreatic cancer refractory to standard-dose-rate gemcitabine: a single-institute study. 2009
Show List of Full Article Records
Google Searches

Learn more about Xiaobai Li using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Ohio State University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Ohio State University
2014
  • Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH. · Department of Internal Medicine, The Ohio State University, Columbus, OH. · Center for Biostatistics, The Ohio State University, Columbus, OH. · Department of Surgery, The Ohio State University, Columbus, OH. · Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, OH. · Pubmed 24046122
2013
  • Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA. · Pubmed 22786786
2011
  • Ohio State University Comprehensive Cancer Center, Arthur James Cancer Hospital, Columbus, OH, 43210, USA. · Pubmed 20461379
2009
  • Department of Medicine, The Ohio State University Medical Center, Columbus, OH 43210, USA. · Pubmed 19307739
Yearly article counts 000001101010
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.